Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
MD Anderson cancer center
Apr 17, 2024, 18:24 |
Insight
Myeloma paper of the Day suggested by Robert Orlowski, April 17th
Robert Orlowski, Director of the Myeloma Section at MD Anderson Cancer Center, shared on X:…
Apr 17, 2024, 17:23 |
Blog
Vivek Subbiah: Should we consider them 2nd generation PARP inhibitors or a completely NEW class of drugs?
Vivek Subbiah shared a post on X: "More than a dozen PARP1 selective drugs in different…
Apr 17, 2024, 10:38 |
Insight
Myeloma Paper of the Day - Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X/Twitter: "Myeloma…
Apr 17, 2024, 10:31 |
Insight
Myeloma Paper of the Day - Robert Orlowski
Robert Orlowski, Director of the Myeloma Section at MD Anderson Cancer Center, shared on X:…
Apr 17, 2024, 05:18 |
Blog
Naveen Pemmaraju: Wonderful to spend time today with MPNGuru Professor Radek Skoda
Naveen Pemmaraju shared a post on X: "Meeting of the MPN minds today in Houston…
Apr 17, 2024, 00:56 |
Insight
Cathy Eng: I had an amazing opportunity to work with these phenomenal people
Cathy Eng shared a post on X: "I had an amazing opportunity to work with…
Apr 17, 2024, 00:49 |
Blog
Hind Rafei: Tour de force presentation today by Dr. Katy Rezvani at the Allison Institute
Hind Rafei, Assistant Professor in the Department of Stem Cell Transplantation and Cellular Therapy at…
Apr 17, 2024, 00:22 |
Insight
Jeffrey Lee: Very important work from Banu Arun, Weniy Wang and their team for developing new risk prediction models for Li-Fraumeni syndrome
Jeffrey Lee, Chief Cancer Network Officer and Deputy Chief Operating Officer at MD Anderson Cancer…
Apr 15, 2024, 21:22 |
Blog
Michelyn Smith: Let's spread awareness about clinical trials
Michelyn Smith, Head of Talent Acquisition at Sarah Cannon Research Institute, shared a post by Vivek…
Apr 15, 2024, 16:12 |
Insight
Michael Wang: Our Phase I TRANSCEND trial demonstrated that Liso-cel results in consistently high objective response rates
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
91
92
93
94
95
All:
1246
Posts:
921 - 930
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Uniting Forces: Leveraging Cancer Research to Revolutionize Tuberculosis Treatment
Lance Armstrong and Testicular Cancer: Story, Symptoms, Treatment
Honoring Jeff Weber, a giant in the field of oncology
Douglas Flora: The Great Wave off Kanagawa captures my feelings on certain days
Facebook
RSS Feed
Twitter
Linkedin
Youtube